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Increased of resistant to antibiotics among bacteria isolated from burn wounds
The burn wound can be considered as one of the major health 
problems in the world.¹ The most important factors that inﬂ uence 
morbidity and mortality from burn wound infection and sepsis 
include burning more than 30% of total body surface area (TBSA), 
signiﬁ cant amounts of full-thickness burns, prolonged open wounds 
or delayed initial burn wound care.² 
A typical burn wound is initially colonized predominantly with 
gram-positive organisms which are rapidly replaced by antibiotic-
susceptible gram-negative organisms, usually within a week of 
the burn injury. Risk factors identiﬁ ed in patients colonized with 
drug-resistant organisms include prior use of third-generation 
cephalosporins and antibiotics active against anaerobes, critically 
ill patients with severe underlying disease or immunosuppression, 
and prolonged hospital stay.² Organisms of particular concern are 
methicillin-resistant Staphylococcus aureus (MRSA), enterococci, 
group A b-hemolytic streptococcus, gram-negative rods such 
as Pseudomonas aeruginosa, Acinetobacter spp, E. coli and K. 
pneumoniae.³ 
The pattern of antimicrobial susceptibility of S. aureus and 
other organisms has changed worldwide, especially in developing 
countries that antimicrobial agents have become increasingly less 
effective.4 
Historically, group A beta-hemolytic Streptococcus was the 
most frequent cause of life-threatening burn wound and systemic 
infections. The use of penicillin altered the spectrum of gram-
positive pathogens, leading to the emergence of S. aureus as the 
most common gram-positive early colonizer of the burn wound.5 
Within approximately 6 years, 25% of hospital strains were resistant. 
One to two decades later, 25% of community isolates were penicillin 
resistant. Although the rates are approximation, they have been 
collected based on reports from numerous locations. Hence, a 
clear association can be seen between the prevalence of penicillin 
resistant strains of S. aureus reported in hospitals and the rates in the 
community.6 The latest studies suggest the resistance rate to vary 
from 97.5% (penicillin) and 69.85% (oxacillin) to 3% for vancomycin.3,7-9
Gram-negative pathogens continue to cause the most 
severe infections in burn patients. Recent survey of 104 U.S. burn 
units reports P. aeruginosa (44%) and methicillin-resistant S. aureus 
(MRSA) (33%) as the most prevalent organisms isolated in burn 
centers. Other pathogens in this report are acinetobacter (9%) and 
vanocomycin-resistant enterococci (5%) respectively.10
Selection and dissemination of intrinsic and acquired resistance 
mechanisms increase the probability of burn wound colonization 
due to resistant of species such as P. aeruginosa. P. aeruginosa is 
inherently resistant to common antibiotics and continue its survival 
even in common antiseptics. All this makes the organism difﬁ cult to 
eradicate from the patient as well as from the environment.11 Recent 
studies suggestthe resistance rate to piperacillin; 65.8%, imipenem; 
62%, ciproﬂ oxacin; 60.25%, gentamicin; 63.3%, and ceftazidime to be 
65%.3, 5, 7, 8, 12, 13
In the past few years, A. baumannii has emerged as a 
common pathogen in burn units, often with increasing antimicrobial 
resistance. Chim et al (2007). found Acinetobacter spp. to be highly 
prevalent in Singapore, mainly due to constant introduction of 
Acinetobacter spp. carried on human skin (endemic to tropical 
climate) with every admitted patient.³ The impact of the affected 
patients had clinical evidence of infection requiring a treatment with 
a carbapenem antibiotic and acquisition of A. baumannii, associated 
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with an increased length of stay in the burn unit. The attributable 
mortality rate was estimated to be approximately 12%.14 Recent 
studies suggest following resistant rates for A. baumannii strains 
such piperacillin (75.8 %), imipenem (69%), ciproﬂ oxacin (86.2%), 
gentamicin (85%), and ceftazidime (90%).3, 7, 8, 12, 16, 17
Once MDR strains become established in hospital 
environments they can persist for months.¹ Therefore, the growth 
of MDR organisms such as Acinetobacter, resistant to quinolones, 
cephalosporins, and carbapenems should be considered as key risks 
of burn wound infections. 
Microbial colonization and antibiotic sensitivity trends in burn 
over time necessitate periodic monitoring of these changes in each 
burn center separately.12 Aggressive infection control measures 
should be applied to restrict the emergence and spread of multidrug-
resistant pathogens.
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